Methods for treating cardiac hypertrophy by administering IFN-γ
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jan 24, 2006
Grant Date -
N/A
app pub date -
Nov 16, 2000
filing date -
Apr 2, 1998
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The invention concerns the treatment of cardiac hypertrophy by interferon-gamma (IFN-γ). Cardiac hypertrophy may result from a variety of diverse pathologic conditions, including myocardial infarction, hypertension, hypertrophic cardiomyopathy, and valvular regurgitation. The treatment extends to all stages of the progression of cardiac hypertrophy, with or without structural damage of the heart muscle, regardless of the underlying cardiac disorder.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully